In colon cancer, lncRNA H19 competitively combined with miR-138 and miR-200a, up-regulating the expression of key genes in EMT (VIM, ZEB1, and ZEB2), and promoting the progress of EMT [26]. This evidence concerns the gene H19 and malignant colon neoplasm.